|
|
Blood, 1 October 2004, Vol. 104, No. 7, pp. 2181-2183.
Prepublished online as a Blood First Edition Paper on June 15, 2004; DOI 10.1182/blood-2004-01-0332.
 Previous Article | Table of Contents | Next Article 
RED CELLS
Brief report
Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5'-UTR of the HAMP gene
Thomas Matthes,
Patricia Aguilar-Martinez,
Loredana Pizzi-Bosman,
Régis Darbellay,
Laura Rubbia-Brandt,
Emilio Giostra,
Martine Michel,
Tomas Ganz, and
Photis Beris
From the Division of Hematology, University Hospital, Geneva, Switzerland; the Hematology Laboratory, Centre Hospitalier Universitaire, Montpellier, France; the Division of Clinical Pathology, University Hospital Geneva, Switzerland; the Division of Gastroenterology, University Hospital Geneva, Switzerland; and the Department of Medicine, University of California, Los Angeles.
Juvenile hereditary hemochromatosis is a genetically heterogeneous disorder transmitted as an autosomal recessive trait. It is most often caused by mutations in the HJV gene and rarely in the HAMP gene. Hepcidin is considered to constitute a negative regulator of iron absorption, and its production is increased in inflammatory states and iron overload. We report the detection of a new mutation in the HAMP gene leading to juvenile hemochromatosis in 2 members of a Portuguese family. The mutation lies in the 5'-UTR (untranslated region) of the gene and creates a new initiation codon in the context of a Kozak sequence. We found no trace of hepcidin protein in the patients' urine, suggesting that ribosomes select the mutant initiation codon for translation. The decrease of hepcidin production would thus lead to increased iron absorption, resulting in iron deposition in parenchymal tissues. Phlebotomy therapy of the 2 patients resulted in impressive clinical improvement. (Blood. 2004;104: 2181-2183)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Hemojuvelin and hepcidin: the keys to JH?
- Eric Nisbet-Brown
Blood 2004 104: 1918-1919.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
S. E. Calvo, D. J. Pagliarini, and V. K. Mootha
Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans
PNAS,
May 5, 2009;
106(18):
7507 - 7512.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-L. Island, A.-M. Jouanolle, A. Mosser, Y. Deugnier, V. David, P. Brissot, and O. Loreal
A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis
Haematologica,
May 1, 2009;
94(5):
720 - 724.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Aldred, R. D. Machado, V. James, N. W. Morrell, and R. C. Trembath
Characterization of the BMPR2 5'-Untranslated Region and a Novel Mutation in Pulmonary Hypertension
Am. J. Respir. Crit. Care Med.,
October 15, 2007;
176(8):
819 - 824.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rideau, B. Mangeat, T. Matthes, D. Trono, and P. Beris
Molecular mechanism of hepcidin deficiency in a patient with juvenile hemochromatosis
Haematologica,
January 1, 2007;
92(1):
127 - 128.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Camaschella
Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders
Blood,
December 1, 2005;
106(12):
3710 - 3717.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Porto, A. Roetto, F. Daraio, J. P. Pinto, S. Almeida, C. Bacelar, E. Nemeth, T. Ganz, and C. Camaschella
A Portuguese patient homozygous for the -25G>A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron
Blood,
October 15, 2005;
106(8):
2922 - 2923.
[Full Text]
[PDF]
|
|
|
|
|
